Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Long-Term Deferred Tax: 2020

  • Tango Therapeutics' Long-Term Deferred Tax was N/A to $31,262 in Q4 2020 from the same period last year, while for Dec 2020 it was $31,262, marking a year-over-year change of. This contributed to the annual value of $31,262 for FY2020, which is N/A change from last year.
  • Latest data reveals that Tango Therapeutics reported Long-Term Deferred Tax of $31,262 as of Q4 2020.
  • Tango Therapeutics' 5-year Long-Term Deferred Tax high stood at $31,262 for Q4 2020, and its period low was $31,262 during Q4 2020.
  • Its 1-year average for Long-Term Deferred Tax is $31,262, with a median of $31,262 in 2020.